Headaches, nausea, diarrhea, fatigue, and tingling in extremities are very rare
If you are weighing convenience, safety, cost, and results, this guide breaks down what the science and regulators currently say about oral GLP-1 approaches both approved pills and the unregulated "drops" sold online compared to established injectable therapies
Efinopegdutide is another GLP-1R and GCGR dual agonist currently under clinical investigation, which is being explored in studies for patients with obesity, type 2 diabetes (T2D), and metabolically associated fatty liver disease/multiple acyl-CoA dehydrogenase deficiency syndrome (MASLD/MASH)
Resources We Trust Mayo Clinic: Supporting Weight-Loss Medications With Adequate, Tailored Nutrition National Institute of Diabetes and Digestive and Kidney Diseases: Prescription Medications to Treat Overweight & Obesity Massachusetts General Hospital: Fitness for People Taking GLP-1 Agonists: A Comprehensive Guide Cleveland Clinic: This Is How to Lose Weight the Right Way and Keep It Off Yale Medicine: Why Your Cardiologist May Prescribe Semaglutide (Wegovy) Vosoughi K et al
Hou, X., Rooklin, D., Fang, H